Vaginal dilator therapy for women receiving pelvic radiotherapy

Cochrane Database of Systematic Reviews

Volumn 2014, Issue 9, 2014, Pages

  Miles, Tracie ^a   Johnson, Nick ^a  

^a ROYAL UNITED HOSPITALS BATH NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER RADIOTHERAPY; CLINICAL EFFECTIVENESS; FEMALE GENITAL SYSTEM FUNCTION; FEMALE GENITAL TRACT CANCER; FEMALE GENITAL TRACT PARAMETERS; FOLLOW UP; HUMAN; MEDICAL PROCEDURES; MORBIDITY; PELVIS RADIOGRAPHY; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SAFETY; SEXUAL FUNCTION; SEXUAL SATISFACTION; SEXUALITY; STENOSIS; SYSTEMATIC REVIEW; TREATMENT OUTCOME; VAGINAL DILATION THERAPY; VAGINAL INJURY; VAGINAL LUBRICATION; VAGINAL STENOSIS; ADVERSE EFFECTS; BRACHYTHERAPY; CONSTRICTION, PATHOLOGIC; DEVICES; DILATATION; FEMALE; HYPERBARIC OXYGEN; INJURIES; META ANALYSIS; PATHOLOGY; PELVIS; PROCEDURES; RADIATION INJURIES; RADIATION RESPONSE; RADIOTHERAPY; RUPTURE; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; SURGERY; TIME; VAGINA;

ANTIINFLAMMATORY AGENT; BENZYDAMINE; ESTROGEN;

ANTI-INFLAMMATORY AGENTS; BENZYDAMINE; BRACHYTHERAPY; CONSTRICTION, PATHOLOGIC; DILATATION; ESTROGENS; FEMALE; HUMANS; HYPERBARIC OXYGENATION; PELVIS; RADIATION INJURIES; RADIOTHERAPY; RUPTURE; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; TIME FACTORS; VAGINA;

EID: 84942768037     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD007291.pub3     Document Type: Review

References (74)

1. Bahng AY, Dagan A Brunner D, Lin LL. Determination of prognostic factors for vaginal mucosal toxicity associated withintravaginalhigh-dose ratebrachytherapyin patients with endometrial cancer. International Journal of Radiation Oncology, Biology and Physics 2012;82(2):667-673. [: http://www.redjournal.org/article/S0360-3016(10)03651-5/abstract]
2. Bahng AY, Dagan A, Brunner D, Lin LL. Determination of prognostic factors for long-term vaginal toxicity associated with intravaginal high-dose rate brachytherapy in patients with endometrial carcinoma. International Journal of Radiation Oncology, Biology, Physics 2010;78(3 Suppl):S401-2. [: http://www.redjournal.org/article/S0360-3016(10)01919-X/fulltext]
3. Bruner DW, Lanciano R, Keegan M, Corn B, Martin E, Hanks GE. Vaginal stenosis and sexual function following intracavitary radiation for the treatment of cervical and endometrial cancer. International Journal of Radiation Oncology, Biology, Physics 1993;27(4):825-30.
4. Bruner DW, Nolte SA, Shahin MS, Huang HQ, Sobel, E, Gallup D, et al. Measurement of vaginal length: reliability of the vaginal sound-a Gynecologic Oncology Group Study. International Journal of Gynecological Cancer 2006;16(5):1749-55. [: http://journals.lww.com/ijgc/Abstract/2006/09000/Measurement_of_vaginal_length__reliability_of_the.4.aspx]
5. Decruze SB, Guthrie D, Magnani R. Prevention of vaginal stenosis in patients following vaginal brachytherapy. Clinical Oncology 1999;11:46-8.
6. GondiV, Bentzen SM, Sklenar KL, Dunn EF, Petereit DG, Tannehill SP, et al. Severe late toxicities following concomitant chemoradiotherapy compared to radiotherapy alone in cervical cancer: an inter-era analysis. Journal of Radiation Oncology, Biology, Physics 2012;84(4):973-82. [: http://www.redjournal.org/article/S0360-3016(12)00137-X/abstract; PUBMED: http://www.ncbi.nlm.nih.gov/pubmed/22898381]
7. Jeffries SA, Robinson JW, Craighead PS, Keats MR. An effective group psychoeducational intervention for improving compliance with vaginal dilation: a randomized controlled trial. International Journal of Radiation Oncology, Biology, Physics 2006;65(2):404-11.
8. Law E, Kelvin JF, Thom B, Riedel E, Tom A, Goodman KA. Prospective study of vaginal dilator use adherence and efficacy following pelvic and intravaginal radiotherapy. Journal of Clinical Oncology 2013;31(18 Suppl):Abstract 9524. [: http://meetinglibrary.asco.org/content/111935-132]
9. Miles TP. Evaluating vaginal dilator therapy after pelvic radiotherapy [PhD thesis]. Bristol, UK: The University of the West of England Bristol, Faculty of Health and Social Care, 2012.
10. Miles T, Johnson N, Bush M. Vaginal length and elasticity measurements after radiotherapy for gynaecological cancer: Is it necessary to necessary to dilatate the vagina after radiotherapy?. Supported by a research fellowship for M Bush from the Royal United Hospital NHS Trust Research Fund Unpublished data.
11. Poma PA. Postirradiation vaginal occlusion: nonoperative management. International Journal of Gynaecology and Obstetrics 1980;18(2):90-2.
12. Robinson JW, Faris PD, Scott CB. Psychoeducational group increases vaginal dilation for younger women and reduces sexual fears for women of all ages with gynecological carcinoma treated with radiotherapy. International Journal of Radiation Oncology Biology and Physics 1999;44(3):497-506.
13. Sobotkowski J, Markowska J, Fijuth J, Pietraszek A. Preliminary results of mitomycin C local application as post-treatment prevention of vaginal radiation-induced morbidity in women with cervical cancer. European Journal of Gynaecological Oncology 2006;27(4):356-8.
14. Velaskar SM, Martha R, Mahantashetty U, Badakare JS, Shrivastava SK. Use of indigenous vaginal dilator in radiation induced vaginal stenosis. Indian Journal of Occupational Therapy 2007;34(1):3-6.
15. Bruner D. Randomized feasibility study of dilator use and an educational program to increase compliance [National Cancer Institute (USA) funding, Budget Start Date December 2011, end date April 2013]. RePORTER database 2010. [: http://maps.cancer.gov/overview/DCCPSGrants/abstract.jsp?applId=7706328&term=CA140766;: http://projectreporter.nih.gov/project_info_description.cfm?aid=8367931&icde=0;: http://projectreporter.nih.gov/project_info_details.cfm?aid=8367931]
16. Donnelley E, Duffey S. Randomized feasibility study of dilator use and an educational program to increase compliance after vaginal brachytherapy for endometrial cancer (Protocol No: NCI UP10G01). Robert H. Lurie Comprehensive Cancer Center of Northwestern University website 2014.
17. Abitol MM, Davenport JH. Sexual dysfunction after therapy for cervical carcinoma. American Journal of Obstetrics and Gynaecology 1974;119:181-9.
18. Owen Mumford Ltd, Brook Hill, Woodstock, Oxford OX20 1TU. Amielle Comfort. http://www.owenmumford.com/en/range/21/amielle-comfort.html.
19. Bentzen SM. Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology. Nature Reviews Cancer 2006;6:702-13. [: http://www.nature.com/nrc/journal/v6/n9/full/nrc1950.html]
20. Bertelesen K. Sexual dysfunction after treatment of cervical cancer. Danish Medical Bulletin 1983;30:31-4.
21. GMCT Gynaecological Oncology Guidelines Review Group. Vaginal stenosis. Best Clinical Practice Gynaecological Cancer Guidelines (http://www.aci.health.nsw.gov.au/__data/assets/pdf_file/0010/154549/go_clinical_guidelines.pdf?). Sydney: NSW Department of Health, 2009:16. [: ISBN 978-1-74187-444-0]
22. Bonner C, Nattress K, Anderson C, Carter J, Milross C, Philp S, et al. Chore or priority? Barriers and facilitators affecting dilator use after pelvic radiotherapy for gynaecological cancer. Supportive Care in Cancer 2012;20(10):2305-13. [PUBMED: http://www.ncbi.nlm.nih.gov/pubmed/22160621]
23. Burke L. Sexual dysfunction following radiotherapy for cancer of the cervix. British Journal of Nursing 1996;5(4):239-44.
24. Carter J. Vaginal Dilator Therapy. Guidelines for the use of vaginal dilators in women receiving pelvic radiotherapy and brachytherapy treatments. Sydney Local Health District. http://www.sswahs.nsw.gov.au/services/sgog/VD_Therapy.html 2012.
25. Cartwright-Alcarese F. Addressing sexual dysfunction following radiation therapy for gynaecologic malignancy. Oncology Nursing Forum 1995;22(8):1227-31.
26. Crowther ME, Corney RH, Shepherd JH. Editorial. Psychosexual implications of gynaecological cancer. BMJ 1994;308:869-70.
27. Cullen K, Fergus K, Dasgupta T, Fitch M, Doyle C, Adams L. From "sex toy" to intrusive imposition: a qualitative examination of women's experiences with vaginal dilator use following treatment for gynecological cancer. Journal of Sexual Medicine 2012;9(4):1162-73.
28. Davidson SE, Burns M, Routledge J, Swindell R. The impact of radiotherapy for carcinoma of the cervix on sexual function assessed using the LENT SOMA scales. Radiotherapy and Oncology 2003;68(3):241-7.
29. Deeks JJ, Altman DG, Bradburn MJ. Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis. Egger M, Davey Smith G, Altman DG (eds). Systematic Reviews in Health Care: Meta-Analysis in Context (2nd edition). London. BMJ Publication Group, 2001.
30. Denham JW, Hauer-Jensen M. The radiotherapeutic injury-a complex wound. Radiotherapy Oncology 2002;63:129-45.
31. Denton AS, Bond SJ, Mathews S, Bentzen SM, Maher EJ. National audit of the management and outcome of carcinoma of the cervix treated with radiotherapy in 1993. Clinical Oncology 2000;12:347-53.
32. Eltabbakh GH, Piver MS, Hempling RE, Shin KH. Excellent long term survival and absence of vaginal recurrences in 332 patients with low risk stage I endometrial adenocarcinoma treated with hysterectomy and vaginal brachytherapy without formal staging lymph node sampling: report of a prospective trial. International Journal of Radiation Oncology, Biology, Physics 1977;32(2):373-80.
33. EORTC QLQ-C30 Version 3.0. QLQ-C30 Core questionnaire, Lung, Breast, Head and Neck, Ovarian, Oesophageal, Gastric, Cervix, Multiple Myeloma, Oesophago-Gastric, Prostate, Colorectal Liver Metastases, Colorectal, Brain, Endometrial, Information, Bone Metastases, Hepatocellular Carcinoma, Carcinoid/Neuroendocrine Tumours and Elderly Modules. http://groups.eortc.be/qol/eortc-qlq-c30 1995.
34. Faithfull S, Wells M. Supportive Care in Radiotherapy. Edinburgh: Churchill Livingstone, 2003.
35. Fisher J, Fisher W, Misovich S, Kimble D, Malloy T. Changing AIDS risk behaviour: effects of an intervention emphasizing AIDS risk reduction information, motivation and behaviour skills in a college student population. Health Psychology 1996;14:120-8.
36. Gosselin T, Waring J. Nursing management of patients receiving brachytherapy for gynecologic malignancies. Clinical Journal of Oncology Nursing 2001;5(2):59-63.
37. Grigsby PW, Russell A, Bruner D, Eifel P, Koh WJ, Spanos W, et al. Late injury of cancer therapy on the female reproductive tract. International Journal of Radiation Oncology, Biology, Physics 1995;31(5):1281-99.
38. Hartman P, Diddle AW. Vaginal stenosis following irradiation therapy for carcinoma of the cervix uteri. Cancer 1972;30(2):426-42.
39. Hassey-Dow K. Altered patterns of sexuality. Nursing Care in Radiation Oncology. Philadelphia: WB Saunders, 1992.
40. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-60.
41. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
42. Hoffman MS, Wakeley KE, Cardosi RJ. Risks of rigid dilation for a radiated vaginal cuff: two related rectovaginal fistulas. Obstetrics and Gynecology 2003;101(5 Pt 2):1125-6.
43. Johnson N, Lilford R. Chapter 25: The surgical treatment of gynaecological congenital malformations. In: Studd J editor(s). Progress in Obstetrics and Gynaecology. 8th Edition. Edinburgh: Churchill Livingstone, 1990:413-31.
44. Johnson N, Batchelor A, Lilford RJ. Experience with tissue expansion vaginoplasty. British Journal of Obstetrics and Gynaecology 1991;98:564-8. [: http://onlinelibrary.wiley.com/doi/10.1111/j.1471-0528.1991.tb10371.x/full]
45. Krumm S, Lamberti J. Changes in sexual behaviour following radiation therapy for cervical cancer. Journal of Psychosomatic Obstetric Gynaecology 1993;14(1):51-63.
46. Lamberti J. Sexual adjustment after radiation therapy for cervical carcinoma, a brief guide to office counselling. Medical Aspects of Human Sexuality 1979;13:87-8.
47. Lancaster L. Preventing vaginal stenosis after brachytherapy for gynaecological cancer: an overview of Australian practices. European Journal of Oncology Nursing 2004;8(1):30-9.
48. Macmillan Cancer Support. Side effects of radiotherapy for cervical cancer (Cancer Backup). http://www.macmillan.org.uk/Cancerinformation/Cancertypes/Cervix/Treatingcervicalcancer/Radiotherapy/Sideeffectsofradiotherapy.aspx 2012 (last accessed 1 July 2014).
49. Holmes L, Miles T, Punt L, Golby S, Kent E, Smith L. Guidance on Long Term Consequences of Treatments for Gynaecological Cancer. Part 1: Radiotherapy. London: Macmillan Cancer Support, 2014. [: http://www.macmillan.org.uk/Documents/AboutUs/Health_professionals/MAC14942_GYNAE_GUIDE.pdf]
50. MEDintim Personal Healthcare. Vaginal Dehnungshilfen aus Silikon. http://medintim-shop.de/Fuer-die-Frau/Vaginal-Dilatoren/Dilator-Set.html?gclid=CKKuwIGHjZ8CFU0B4wodtGTfIQ (accessed 2 July 2010).
51. Miles TP. Vagina monologues. Annual National Meeting of the British Society for the Study of Vulval Disease. University of Cardiff, April 2008.
52. Miles TP, Johnson N. Systematic literature review, a randomised trial and a preference trial challenging the practiceof vaginal dilation during radiotherapy. 13th Biennial Meeting of the International Gynaecological Cancer Society (IGCS 2010), Prague, Czech Republic. 2010.
53. National Cancer Institute: US National Institutes of Health. Cancer of the uterus. http://www.cancer.gov/cancertopics/wyntk/uterus (accessed 2 July 2010).
54. National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCAE) Version 3. Department of Health and Human Services, National Institutes of Health 2006. [: http://ctep.cancer.gov/protocolDevelopment/electronic_applications/docs/ctcaev3.pdf]
55. National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCAE) Version 4.02 U.S. NIH Publication No. 03-5410. Department of Health and Human Services, National Institutes of Health 2009. [: http://evs.nci.nih.gov/ftp1/CTCAE/Archive/CTCAE_4.02_2009-09-15_QuickReference:8.5x11.pdf]
56. Pavy JJ, Denekamp J, Letschert J, Littbrand B, Mornex F, Bernier J, et al. EORTC Late Effects Working Group. Late effects toxicity scoring: the SOMA scale. Radiotherapy and Oncology 1995;35:11-5.
57. Pountney D. From clinic to commerce. Cancer Nursing Practice 2005;4:9.
58. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
59. Rice A. Sexuality in cancer and palliative 1: Effects of disease and treatment. International Journal of Palliative Nursing 2000;6(8):392-7.
60. Schimpf MO, Harvie HS, Omotosho TB, Epstein LB, Jean-Michel M, Olivera CK, et al. Does vaginal size impact sexual activity and function?. International Urogynecology Journal 2010;21(4):447-52.
61. Schover LR. Sexuality & cancer: for the woman who has cancer, and her partner. American Cancer Society 1988.
62. Seibel M, Freeman M, Graves W. Sexual function after surgical and radiation therapy for cervical carcinoma. Southern Medical Journal 1982;75:1195-7.
63. Soul Source Enterprises. Soul Source Silicone Dilators. http://www.soulsourceenterprises.com/html/products_silicone.html (accessed 2 July 2010).
64. Best practice guidelines on the use of vaginal dilators in women receiving pelvic radiotherapy. National Forum of Gynaecological Oncology Nurses (http://www.jotrust.co.uk/files/PDF%20to%20download/23198_Dilators_A4_fnl_AW.pdf). Oxon: Owen Mumford, July 2005.
65. Vasika A, Popovitch NR, Brausch CC. Post radiation course of patients with cervical carcinoma. Obstetrics and Gynaecology 1958;11:403-14.
66. Weber AM, Walters MD, Schover LR, Mitchinson A. Vaginal anatomy and sexual function. Obstetrics and Gynecology 1995;86(6):946-9.
67. White I, Faithfull S. UK survey of current practice in vaginal dilatation associated with pelvic radiotherapy. European Institute of Health and Medical Sciences 2004.
68. White ID, Faithfull S. Vaginal dilation associated with pelvic radiotherapy: a UK survey of current practice. International Journal of Gynecological Cancer 2006;16:1140-6.
69. Wilmoth MC, Spinelli A. Sexual implications of gynecologic cancer treatments. Journal of Obstetric, Gynecologic, and Neonatal Nursing 2000;29(4):413-21.
70. Denton AS, Maher EJ. Interventions for the physical aspects of sexual dysfunction in women following pelvic radiotherapy. Cochrane Database of Systematic Reviews 2003, Issue 1. [DOI: 10.1002/14651858.CD003750]
71. Johnson N, Miles TP, Cornes P. Dilating the vagina to prevent damage from radiotherapy; systematic review of the literature. British Journal of Obstetrics and Gynaecology 2010;117(5):522-31.
72. Miles T, Johnson N. Vaginal dilator therapy for women receiving pelvic radiotherapy. Cochrane Database of Systematic Reviews 2010, Issue 9. [DOI: 10.1002/14651858.CD007291.pub2]
73. Miles TP. Chapter 5. Evaluating vaginal dilator therapy after pelvic radiotherapy [PhD thesis]. Bristol, UK: University of the West of England Bristol, Faculty of Health and Social Care, 2012.
74. Miles T. International Guidelines on Vaginal Dilation after Pelvic Radiotherapy. 1st Edition. Oxford, UK: Owen Mumford, 2012. [: http://www.ncsi.org.uk/wp-content/uploads/Inter-Best-Practice-Guide-Vaginal-Dilators-July-2012.pdf]